What is the best management approach for inadvertent tissue extravasation of intravenous (IV) dopamine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Inadvertent Tissue Extravasation of Intravenous Dopamine

Local infiltration of phentolamine is the best management approach for inadvertent tissue extravasation of intravenous dopamine. 1

Mechanism of Dopamine Extravasation Injury

Dopamine is a vasoactive medication that can cause severe tissue injury when extravasated into surrounding tissues. The mechanism of injury involves:

  1. Local vasoconstriction due to alpha-adrenergic effects
  2. Tissue ischemia leading to potential necrosis
  3. Severe skin injury that may require surgical intervention if not promptly treated

Evidence-Based Management

The American Academy of Pediatrics guidelines specifically recommend phentolamine for dopamine extravasation. The recommended dose is 0.1-0.2 mg/kg (up to 10 mg) diluted in 10 mL of 0.9% sodium chloride injected intradermally at the extravasation site 1. This treatment counteracts the dermal vasoconstriction caused by dopamine.

The FDA drug label for dopamine also acknowledges that extravasation can result in severe skin injury and notes that phentolamine injected intradermally at the extravasation site may be helpful for counteracting dermal vasoconstriction 2.

Management Algorithm

  1. Immediate recognition and intervention:

    • Stop the dopamine infusion immediately
    • Elevate the affected limb if possible
  2. Phentolamine administration:

    • Prepare phentolamine: 0.1-0.2 mg/kg (maximum 10 mg) diluted in 10 mL of normal saline
    • Inject intradermally around the periphery of the extravasation site
    • Administer as soon as possible after extravasation is detected
  3. Monitoring and follow-up:

    • Assess the site frequently for signs of improved perfusion
    • Monitor for resolution of blanching and return of normal skin color
    • Document the event and intervention

Alternative Options

While phentolamine is the first-line treatment, other options have been studied:

  • Topical nitroglycerin has shown some efficacy in case reports 3, but has less supporting evidence than phentolamine
  • Terbutaline has been suggested as an alternative when phentolamine is unavailable 4

Prevention Strategies

To prevent dopamine extravasation:

  • Use central venous access whenever possible for dopamine infusion
  • If peripheral administration is necessary, use a large vein (preferably antecubital fossa)
  • Use a long intravenous catheter (at least 20 gauge or larger)
  • Frequently inspect the IV site for signs of extravasation 5

Common Pitfalls to Avoid

  1. Delayed recognition: Tissue damage can progress rapidly; immediate intervention is crucial
  2. Inadequate treatment: Simply stopping the infusion without antidote administration is insufficient
  3. Misconception about dose-related risk: Even low-dose dopamine infusions can cause severe extravasation injury 5
  4. Using ice: Ice may worsen vasoconstriction and is not recommended
  5. Relying only on topical treatments: Local infiltration with phentolamine is more effective than topical treatments alone

Phentolamine works by directly antagonizing the alpha-adrenergic effects of dopamine, making it the most effective treatment for reversing the vasoconstriction and preventing tissue necrosis 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Alternative Pharmacological Management of Vasopressor Extravasation in the Absence of Phentolamine.

P & T : a peer-reviewed journal for formulary management, 2017

Research

Extravasation injury associated with low-dose dopamine.

The Annals of pharmacotherapy, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.